1991 – 1995

1995

Dr Linda Lashford £16,000: Patterson Institute, Christie Hospital, Manchester, England
The cost of meeting quality control procedures necessary to manufacture clinical trial grade material for gene therapy for MPS I, Hurler disease.

Dr Gail Lebens £18,000: Patterson Institute, Christie Hospital, Manchester, England
Final year of a three-year grant to develop “Gene Therapy for MPS I, Hurler disease”.

1994

Dr Bryan Winchester £15,635: Institute of Child Health, London, England
One year grant to carry out mutation analysis of MPS in a research setting.

Dr Gail Lebens £16,000: Patterson Institute, Christie Hospital, Manchester, England
Year two of a three-year grant to develop “Gene Therapy for MPS I, Hurler disease”.

1993

Miss Lesley Heptinstall £9,000; Willink Biochemical Genetics Unit, Royal Manchester Children’s Hospital, England
Final year of a three-year grant (60% of annual salary) to fund the post of senior biochemist applying DNA technology to the diagnosis and carrier testing for MPS diseases.

Dr Ruth McDermott £15,000; Patterson Institute, Christie Hospital, Manchester, England
Year one of a three-year grant to develop “Gene Therapy for MPS I, Hurler disease”.

1992

Miss Lesley Heptinstall £11,000: Willink Biochemical Genetics Unit, Royal Manchester Children’s Hospital, England
Year two of a three-year grant (60% of annual salary) to fund the post of senior biochemist applying DNA technology to the diagnosis and carrier testing for MPS diseases.

Dr James Edmond Wraith £18,000: Willink Biochemical Genetics Unit, Royal Manchester Children’s Hospital, England
Six-month extension to final year grant of a four-year appointment as Consultant Paediatrician to specialise in the diagnosis and clinical management of MPS children and their families throughout the United Kingdom. At this point Salford Health Authority took over the responsibility for funding Dr Wraith’s post of Consultant Paediatrician

1991

Dr Bryan Winchester £1,000: Institute of Child Health, London, England
Consumables to facilitate the biochemical screening in the diagnosis of children with MPS III, Sanfilippo disease.

Miss Lesley Heptinstall £10,000; Willink Biochemical Genetics Unit, Royal Manchester Children’s Hospital, England
Year one of a three-year grant (60% of annual salary) to fund the post of senior biochemist applying DNA technology to the diagnosis and carrier testing for MPS diseases.

Dr John Walters £36,000: Willink Biochemical Genetics Unit, Royal Manchester Children’s Hospital, England
Year one of a two-year appointment for a second Consultant Paediatrician to specialise in the diagnosis and clinical management of MPS children and their families throughout the United Kingdom.
This grant was discontinued after one year and Salford Health Authority took over the funding of this post.

Dr James Edmond Wraith £27,700: Willink Biochemical Genetics Unit, Royal Manchester Children’s Hospital, England
Final year of a four-year appointment as Consultant Paediatrician to specialise in the diagnosis and clinical management of MPS children and their families throughout the United Kingdom.